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Abstract
To the Editor: Alcohol induced hepatic oxidative stress and inflammation is known to cause liver injury. An
increase in reactive oxidative species (ROS) from alcohol consumption leads to oxidative stress [1]. This can
activate the inflammatory cytokines, IL-6 and TNF-α which promote liver injury. Both IL-6 and TNF-α are
activated and transcribed by the inflammatory molecule, NFκB [2]. We read the interesting paper by Liu et al.,
entitled, “Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-
metabolizing modulating in rats”, published in your journal recently [3]. The authors demonstrated that
oleanolic acid can reduce hepatic injury by elevating Nrf-2 related antioxidants, reduce inflammation, and
increase ethanol metabolism. We believe that the mechanism of modulating these signalling pathways could
be important for understanding the protective effects of oleanolic acid.
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Comment on: Oleanolic acid co-administration alleviates ethanol-induced hepatic 
injury via Nrf-2 and ethanol-metabolizing modulating in rats 
To the Editor: Alcohol induced hepatic oxidative stress and inflammation is known to cause 
liver injury.  An increase in reactive oxidative species (ROS) from alcohol consumption leads 
to oxidative stress[1]. This can activate the inflammatory cytokines, IL-6 and TNF-α which 
promote liver injury. Both IL-6 and TNF-α are activated and transcribed by the inflammatory 
molecule, NFκB[2]. We read the interesting paper by Liu et al., entitled, “Oleanolic acid co-
administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing 
modulating in rats”, published in your journal recently [3]. The authors demonstrated that 
oleanolic acid can reduce hepatic injury by elevating Nrf-2 related antioxidants, reduce 
inflammation, and increase ethanol metabolism. We believe that the mechanism of 
modulating these signalling pathways could be important for understanding the protective 
effects of oleanolic acid.  
Firstly, the reduction of oxidative stress and inflammatory signalling pathways by oleanolic 
acid may contribute to decreased liver injury as shown by the authors. In this study, it has 
been shown that IL-6 and TNF-α elevation was attenuated by oleanolic acid administration, 
however, NFκB was not examined. Oleanolic acid has been found to reduce NFκB signaling 
by inhibiting LPS-induced phosphorylation of IkB, and subsequently the expression of the 
cytokines TNF-α and IL-1[4].  Thus, a reduction in NFκB signalling by oleanolic acid may 
cause the reduced expression of the cytokines IL-6 and TNF-α found in this study. However, 
whether oleanolic acid directly targets NFκB in alcohol induced liver injury remains 
unknown. Therefore, whether oleanolic acid can directly inhibit NFκB leading to a 
subsequent reduction in activation and transcription of inflammatory cytokines may also be 
important in the attenuation of alcohol induced liver injury. Oleanolic acid has been shown to 
directly inhibit intracellular signalling molecules including PTP1B, a molecule that can be 
activated by NFκB[5]. This interaction occurs by oleanolic acid binding directly to site B of 
PTP1B, leading to its inhibition.  
In addition, it has been found that Nrf2 and NFκB signalling pathways cross-talk[6]. Nrf2 has 
been found to be activated as a result of NFκB induced inflammation and ROS production as 
a defensive response. Nrf2 activation also causes reduced hepatic inflammatory genes 
including IL-6, and TNF-α. Therefore, it would be interesting to compare the effects of 
oleanolic acid on the activity of both Nrf-2 and NFκB signalling pathways in order to 
determine their role in alcohol induced liver injury.  
In conclusion, the ability of oleanolic acid to influence the activity of Nrf2 and NFκB 
signalling suggests potential targets of this compound in these molecular signalling pathways. 
Further studies are required to elucidate the exact mechanisms linking Nrf2 and NFκB to 
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